Considering the antimicrobial sensitivity of the intestinal botulism agent Clostridium butyricum when treating concomitant infections

Eur J Epidemiol. 2003;18(12):1153-4. doi: 10.1023/b:ejep.0000006630.59370.88.

Abstract

In Italy, neurotoxigenic Clostridium butyricum has been reported as a new agent of intestinal toxemia botulism, and most of the cases have been associated with enterocolitis. Although infections concomitant with botulism must be treated with antibiotics, this can increase the severity of botulism. We discuss the sensitivity of this agent to certain antibiotics, compared to findings on the sensitivity of C. botulinum.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use*
  • Botulism / complications
  • Botulism / drug therapy*
  • Botulism / microbiology
  • Clostridium botulinum
  • Drug Resistance
  • Humans
  • Italy
  • Toxemia

Substances

  • Anti-Bacterial Agents